Lilach Kleinberg

1.3k total citations
27 papers, 1.1k citations indexed

About

Lilach Kleinberg is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lilach Kleinberg has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lilach Kleinberg's work include Cell death mechanisms and regulation (10 papers), Cancer Research and Treatments (5 papers) and Cancer Genomics and Diagnostics (5 papers). Lilach Kleinberg is often cited by papers focused on Cell death mechanisms and regulation (10 papers), Cancer Research and Treatments (5 papers) and Cancer Genomics and Diagnostics (5 papers). Lilach Kleinberg collaborates with scholars based in Norway, Israel and United States. Lilach Kleinberg's co-authors include Ben Davidson, Viví Ann Flørenes, Jahn M. Nesland, Claes G. Tropé, Arild Holth, Hiep Phuc Dong, Ie‐Ming Shih, Elise C. Kohn, Odd Terje Brustugun and Bjørn Risberg and has published in prestigious journals such as Cancer, Clinical Cancer Research and Nature Protocols.

In The Last Decade

Lilach Kleinberg

27 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lilach Kleinberg Norway 19 521 387 252 248 179 27 1.1k
M. J. Birrer United States 14 947 1.8× 537 1.4× 337 1.3× 115 0.5× 244 1.4× 24 1.5k
L. M. Ellis United States 12 585 1.1× 371 1.0× 244 1.0× 225 0.9× 67 0.4× 20 1.1k
Benoît Thibault France 12 409 0.8× 312 0.8× 185 0.7× 84 0.3× 160 0.9× 21 797
Mingo M. H. Yung Hong Kong 18 874 1.7× 293 0.8× 566 2.2× 245 1.0× 222 1.2× 23 1.3k
Xiangbing Meng United States 24 912 1.8× 439 1.1× 225 0.9× 120 0.5× 116 0.6× 58 1.3k
Yumi Yokoyama United States 16 729 1.4× 309 0.8× 379 1.5× 97 0.4× 186 1.0× 36 1.1k
Katsuhide Yoshidome Japan 16 610 1.2× 580 1.5× 271 1.1× 135 0.5× 126 0.7× 61 1.3k
Marsela Braunstein Canada 11 638 1.2× 450 1.2× 374 1.5× 137 0.6× 320 1.8× 15 1.4k
Ling Cen United States 17 626 1.2× 569 1.5× 197 0.8× 151 0.6× 251 1.4× 44 1.3k
Minshu Yu United States 20 541 1.0× 516 1.3× 155 0.6× 77 0.3× 56 0.3× 37 959

Countries citing papers authored by Lilach Kleinberg

Since Specialization
Citations

This map shows the geographic impact of Lilach Kleinberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilach Kleinberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilach Kleinberg more than expected).

Fields of papers citing papers by Lilach Kleinberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lilach Kleinberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilach Kleinberg. The network helps show where Lilach Kleinberg may publish in the future.

Co-authorship network of co-authors of Lilach Kleinberg

This figure shows the co-authorship network connecting the top 25 collaborators of Lilach Kleinberg. A scholar is included among the top collaborators of Lilach Kleinberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lilach Kleinberg. Lilach Kleinberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davidson, Ben, et al.. (2021). Primary uterine ectomesenchymoma harboring a DICER1 mutation: case report with molecular analysis. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 479(2). 419–424. 4 indexed citations
2.
Fjellbirkeland, Lars, Pål Suhrke, Peter Jebsen, et al.. (2015). EGFR mutation testing of lung cancer patients – Experiences from Vestfold Hospital Trust. Acta Oncologica. 55(2). 149–155. 9 indexed citations
3.
Kleinberg, Lilach, Peter Jebsen, Marius Lund‐Iversen, Åslaug Helland, & Lars Fjellbirkeland. (2014). EGFR-mutated lunge cancer in a general Norwegian population. 44. 2746. 1 indexed citations
4.
Lund‐Iversen, Marius, Lilach Kleinberg, Lars Fjellbirkeland, Åslaug Helland, & Odd Terje Brustugun. (2012). Clinicopathological Characteristics of 11 NSCLC Patients with EGFR-Exon 20 Mutations. Journal of Thoracic Oncology. 7(9). 1471–1473. 52 indexed citations
5.
Brustugun, Odd Terje, Åslaug Helland, Lars Fjellbirkeland, et al.. (2012). Mutasjonstesting ved ikke-småcellet lungekreft. Tidsskrift for Den norske legeforening. 132(8). 952–955. 5 indexed citations
6.
Helland, Åslaug, Lilach Kleinberg, Thomas Fleischer, et al.. (2011). EGFR Gene Alterations in a Norwegian Cohort of Lung Cancer Patients Selected for Surgery. Journal of Thoracic Oncology. 6(5). 947–950. 39 indexed citations
7.
Annunziata, Christina M., Helene Tuft Stavnes, Lilach Kleinberg, et al.. (2010). Nuclear factor κB transcription factors are coexpressed and convey a poor outcome in ovarian cancer. Cancer. 116(13). 3276–3284. 128 indexed citations
8.
Elstrand, Mari Bunkholt, Lilach Kleinberg, Elise C. Kohn, Claes G. Tropé, & Ben Davidson. (2009). Expression and Clinical Role of Antiapoptotic Proteins of the Bag, Heat Shock, and Bcl-2 Families in Effusions, Primary Tumors, and Solid Metastases in Ovarian Carcinoma. International Journal of Gynecological Pathology. 28(3). 211–221. 33 indexed citations
9.
Kleinberg, Lilach, Hiep Phuc Dong, Arild Holth, et al.. (2009). Cleaved caspase-3 and nuclear factor-κB p65 are prognostic factors in metastatic serous ovarian carcinoma. Human Pathology. 40(6). 795–806. 50 indexed citations
10.
Dong, Hiep Phuc, Lilach Kleinberg, Ben Davidson, & Bjørn Risberg. (2008). Methods for simultaneous measurement of apoptosis and cell surface phenotype of epithelial cells in effusions by flow cytometry. Nature Protocols. 3(6). 955–964. 21 indexed citations
11.
Kleinberg, Lilach, Arild Holth, Claes G. Tropé, Reuven Reich, & Ben Davidson. (2008). Claudin upregulation in ovarian carcinoma effusions is associated with poor survival. Human Pathology. 39(5). 747–757. 68 indexed citations
12.
Kleinberg, Lilach, A. Kathrine Lie, Viví Ann Flørenes, Jahn M. Nesland, & Ben Davidson. (2007). Expression of inhibitor-of-apoptosis protein family members in malignant mesothelioma. Human Pathology. 38(7). 986–994. 52 indexed citations
13.
Kleinberg, Lilach, et al.. (2007). The Diagnostic Role of Claudins in Serous Effusions. American Journal of Clinical Pathology. 127(6). 928–937. 32 indexed citations
14.
Kleinberg, Lilach, Viví Ann Flørenes, Jahn M. Nesland, & Ben Davidson. (2007). Survivin, a Member of the Inhibitors of Apoptosis Family, Is Down-Regulated in Breast Carcinoma Effusions. American Journal of Clinical Pathology. 128(3). 389–397. 17 indexed citations
15.
16.
Davidson, Ben, Zhen Zhang, Lilach Kleinberg, et al.. (2006). Gene Expression Signatures Differentiate Ovarian/Peritoneal Serous Carcinoma from Diffuse Malignant Peritoneal Mesothelioma. Clinical Cancer Research. 12(20). 5944–5950. 88 indexed citations
17.
Davidson, Ben, Lilach Kleinberg, Mai T. Nguyen, et al.. (2006). The mitogen-activated protein kinases (MAPK) p38 and JNK are markers of tumor progression in breast carcinoma. Gynecologic Oncology. 102(3). 453–461. 71 indexed citations
18.
Kleinberg, Lilach, Viví Ann Flørenes, Ilvars Silins, et al.. (2006). Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma. Cancer. 109(2). 228–238. 66 indexed citations
19.
Bercovich, Dani, Yechiel Friedlander, Amnon Hoffman, et al.. (2005). The association of common SNPs and haplotypes in the CETP and MDR1 genes with lipids response to fluvastatin in familial hypercholesterolemia. Atherosclerosis. 185(1). 97–107. 40 indexed citations
20.
Stepensky, David, Lilach Kleinberg, & Amnon Hoffman. (2003). Bone as an Effect Compartment. Clinical Pharmacokinetics. 42(10). 863–881. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. J. Birrer Breakdown of academic impact, for papers by L. M. Ellis Breakdown of academic impact, for papers by Benoît Thibault Breakdown of academic impact, for papers by Mingo M. H. Yung Breakdown of academic impact, for papers by Xiangbing Meng Breakdown of academic impact, for papers by Yumi Yokoyama Breakdown of academic impact, for papers by Katsuhide Yoshidome Breakdown of academic impact, for papers by Marsela Braunstein Breakdown of academic impact, for papers by Ling Cen Breakdown of academic impact, for papers by Minshu Yu
Rankless by CCL
2026